8-KOther Events

BOSTON SCIENTIFIC CORP 8-K Report, Cybersecurity Incident (Sep 8, 2026)

Filed September 8, 2026For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has filed an 8-K detailing the ongoing impact of a significant cybersecurity incident first identified on August 25, 2026. The incident led to a global disruption of IT systems, affecting manufacturing, order processing, and shipping operations. While the Company has made substantial progress in restoring its distribution network and resuming manufacturing at most facilities, full operational recovery is still uncertain. Crucially, BSX now anticipates that this incident will materially impact its third-quarter and full-year 2026 financial results, likely causing the company to miss previously issued net sales growth and adjusted EPS guidance. The company expects to provide a more detailed financial outlook update during its Q3 2026 earnings call in late October. Despite the near-term financial headwinds, BSX currently does not expect the incident to materially affect its long-term financial condition. The investigation into the incident is ongoing, and the company is working with third-party experts to assess and contain the impact. Investors should note that the full extent of revenue recovery and the ultimate financial impact are still being determined. BSX has also highlighted various risks, including potential litigation, reputational damage, and further operational disruptions, that could arise from this cybersecurity event.

Key Highlights

  • 1Boston Scientific (BSX) reported a material cybersecurity incident impacting IT systems, operations, manufacturing, and order fulfillment starting August 25, 2026.
  • 2Significant progress has been made in restoring operations, with the distribution network largely recovered and manufacturing resuming at most global facilities.
  • 3The company now expects to miss its previously issued Q3 and Full Year 2026 financial guidance for net sales growth and adjusted EPS due to the incident's impact.
  • 4A full recovery timeline remains uncertain, and the exact extent of lost revenue is still being assessed, though some recovery is anticipated.
  • 5BSX does not foresee a material impact on its long-term financial condition as a result of this incident.
  • 6The company plans to provide a revised financial outlook during its Q3 2026 earnings call scheduled for October 28, 2026.
  • 7Risks associated with the incident include potential litigation, reputational damage, and ongoing operational challenges.

Frequently Asked Questions

This 8-K filing is to provide an update on a material cybersecurity incident that began on August 25, 2026, and has disrupted Boston Scientific's operations. It also discloses the expected material impact on the company's financial results for the third quarter and full year 2026, leading to a likely miss on previously issued guidance.

The company has made significant progress in restoring operations. Its distribution network is substantially restored, and manufacturing has resumed at most global facilities. However, a full operational recovery timeline is still uncertain, and the investigation is ongoing.

Based on current information, Boston Scientific does not expect the incident to have a material impact on its long-term financial condition. The focus is on near-term operational and financial performance.

Boston Scientific plans to provide an update on its operational and financial outlook for the remainder of fiscal year 2026, incorporating the impact of the incident, during its third-quarter 2026 financial results conference call scheduled for Wednesday, October 28, 2026.